Skip Navigation

Annals of Oncology 2005 16(1):152-157; doi:10.1093/annonc/mdi010
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bidoli, E.
Right arrow Articles by La Vecchia, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bidoli, E.
Right arrow Articles by La Vecchia, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

Original article

Macronutrients, fatty acids, cholesterol and prostate cancer risk

E. Bidoli1,*, R. Talamini1, C. Bosetti2, E. Negri2, D. Maruzzi3, M. Montella4, S. Franceschi5 and C. La Vecchia2,6

1 Servizio di Epidemiologia e Biostatistica, Centro di Riferimento Oncologico, Aviano (PN); 2 Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan; 3 Unità Operativa di Urologia, Azienda Ospedaliera di Pordenone, Pordenone; 4 Servizio di Epidemiologia, Istituto Tumori ‘Fondazione Pascale’, Naples; 6 Istituto di Statistica Medica e Biometria, Università degli Studi di Milano, Milan, Italy; 5 International Agency for Research on Cancer, Lyon Cedex, France

* Correspondence to: Dr E. Bidoli, Unit of Epidemiology and Biostatistics, Centro di Riferimento Oncologico, via Pedemontana Occ., 12, 33081 Aviano (PN), Italy. Tel: +39-0434-659-354; Fax: +39-0434-659-222; Email: epidemiology{at}cro.it

Background: The role of selected macronutrients, fatty acids and cholesterol in the etiology of prostate cancer was analyzed using data from a case–control study carried out in five Italian areas between 1991 and 2002.

Patients and methods: Cases were 1294 men with incident, histologically confirmed prostate cancer, and admitted to the major teaching and general hospitals of study areas. Controls were 1451 men admitted for acute, non-neoplastic conditions to the same hospital network. Information on dietary habits was elicited using a validated food frequency questionnaire including 78 food groups and recipes. Odds ratios (OR) and 95% confidence intervals (CI) were estimated for increasing levels of nutrient intake.

Results: A direct association with prostate cancer was found for starch intake (OR = 1.4 in the highest versus the lowest quintile of intake; 95% CI: 1.1–1.8), whereas an inverse association emerged for polyunsaturated fatty acids (OR = 0.8; 95% CI: 0.6–1.0). Among polyunsaturated fatty acids, linolenic acid (OR = 0.7; 95% CI: 0.6–0.9) and linoleic acid (OR = 0.8; 95% CI: 0.6–1.0) were inversely related to prostate cancer. When the six major macronutrients were included in the same model, the adverse effect of high intake of starch and monounsaturated fatty acids was statistically significant together with the protective effect of polyunsaturated fatty acids. Results were consistent in separate strata of age, body mass index and family history of prostate cancer.

Conclusions: Starch and monounsaturated fatty acids were directly associated with prostate cancer risk and polyunsaturated fatty acids were inversely associated.

Key words: case–control study, diet, macronutrients, prostate cancer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
American Journal of Men's HealthHome page
J. Jayachandran and S. J. Freedland
Prevention of Prostate Cancer: What We Know and Where We Are Going
American Journal of Men's Health, June 1, 2008; 2(2): 178 - 189.
[Abstract] [PDF]


Home page
Clin. Cancer Res.Home page
K. Raina, S. Rajamanickam, R. P. Singh, and R. Agarwal
Chemopreventive Efficacy of Inositol Hexaphosphate against Prostate Tumor Growth and Progression in TRAMP Mice
Clin. Cancer Res., May 15, 2008; 14(10): 3177 - 3184.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. Raina, S. Rajamanickam, G. Deep, M. Singh, R. Agarwal, and C. Agarwal
Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice
Mol. Cancer Ther., May 1, 2008; 7(5): 1258 - 1267.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Raina, M.-J. Blouin, R. P. Singh, N. Majeed, G. Deep, L. Varghese, L. M. Glode, N. M. Greenberg, D. Hwang, P. Cohen, et al.
Dietary Feeding of Silibinin Inhibits Prostate Tumor Growth and Progression in Transgenic Adenocarcinoma of the Mouse Prostate Model
Cancer Res., November 15, 2007; 67(22): 11083 - 11091.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. E. Chavarro, M. J. Stampfer, H. Li, H. Campos, T. Kurth, and J. Ma
A Prospective Study of Polyunsaturated Fatty Acid Levels in Blood and Prostate Cancer Risk
Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1364 - 1370.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Raina, R. P. Singh, R. Agarwal, and C. Agarwal
Oral Grape Seed Extract Inhibits Prostate Tumor Growth and Progression in TRAMP Mice
Cancer Res., June 15, 2007; 67(12): 5976 - 5982.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Torniainen, M. Hedelin, V. Autio, H. Rasinpera, K. A. Balter, A. Klint, R. Bellocco, F. Wiklund, P. Stattin, T. Ikonen, et al.
Lactase Persistence, Dietary Intake of Milk, and the Risk for Prostate Cancer in Sweden and Finland
Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 956 - 961.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.